Read a new publication from Oncowitan: The GTPase Rac1 (Ras-related C3 botulinum toxin substrate 1) is a challenging drug target. The roles of the protein in cancer and the development of small molecules targeting Rac1 are presented.

Rac1 as a therapeutic anticancer target: Promises and limitations,

Biochemical Pharmacology (2022)

Read here

Categories: News